Aldebaran Capital, LLC Pmv Pharmaceuticals, Inc. Transaction History
Aldebaran Capital, LLC
- $109 Billion
- Q3 2025
A detailed history of Aldebaran Capital, LLC transactions in Pmv Pharmaceuticals, Inc. stock. As of the latest transaction made, Aldebaran Capital, LLC holds 504,128 shares of PMVP stock, worth $695,696. This represents 0.65% of its overall portfolio holdings.
Number of Shares
504,128
Previous 515,128
2.14%
Holding current value
$695,696
Previous $546 Million
29.26%
% of portfolio
0.65%
Previous 0.54%
Shares
6 transactions
Others Institutions Holding PMVP
# of Institutions
71Shares Held
40.4MCall Options Held
100Put Options Held
0-
Orbimed Advisors LLC San Diego, CA5.98MShares$8.25 Million0.29% of portfolio
-
Bml Capital Management, LLC Zionsville, IN5.29MShares$7.3 Million6.78% of portfolio
-
Tang Capital Management LLC San Diego, CA4.79MShares$6.6 Million0.3% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO3.3MShares$4.56 Million0.1% of portfolio
-
Sio Capital Management, LLC New York, NY2.64MShares$3.64 Million1.28% of portfolio
About PMV Pharmaceuticals, Inc.
- Ticker PMVP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,622,600
- Market Cap $63M
- Description
- PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...